KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Gains from Sales and Divestitures: 2015-2022

  • Medpace Holdings' Gains from Sales and Divestitures was N/A to $82,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $82,000, marking a year-over-year change of. This contributed to the annual value of $119,000 for FY2021, which is N/A change from last year.
  • Medpace Holdings' Gains from Sales and Divestitures amounted to $82,000 in Q2 2022, which was down 0.00% from $82,000 recorded in Q1 2022.
  • Medpace Holdings' Gains from Sales and Divestitures' 5-year high stood at $119,000 during Q3 2021, with a 5-year trough of $29,629 in Q4 2018.
  • In the last 2 years, Medpace Holdings' Gains from Sales and Divestitures had a median value of $100,500 in 2021 and averaged $100,500.